Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-400
Closed -$22K 6152
2020
Q4
$22K Hold
400
﹤0.01% 6580
2020
Q3
$18K Sell
400
-2,100
-84% -$92.3K ﹤0.01% 6257
2020
Q2
$106K Sell
2,500
-11,800
-83% -$454K ﹤0.01% 5523
2020
Q1
$568K Buy
14,300
+12,800
+853% +$541K ﹤0.01% 3754
2019
Q4
$67K Sell
1,500
-5,800
-79% -$223K ﹤0.01% 6085
2019
Q3
$250K Buy
7,300
+5,900
+421% +$204K ﹤0.01% 4956
2019
Q2
$53K Buy
1,400
+400
+40% +$13.7K ﹤0.01% 6414
2019
Q1
$31K Buy
+1,000
New +$30.5K ﹤0.01% 6707

Other funds holding ACA

Citigroup's ACA Position: Q1 2026 in Review

Citigroup reduced its Arcosa (ACA) stake by 65% in Q1 2026, selling an estimated $3.19M and leaving 14,962 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2820.

Citigroup first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $6.88M in Q4 2024. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Citigroup held 14,962 shares of Arcosa worth $1.59M as of Q1 2026.
  • Citigroup sold 28,096 Arcosa shares in Q1 2026, an estimated $3.19M.
  • Arcosa made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2820 holding.
  • Citigroup first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
  • Citigroup's Arcosa position peaked at $6.88M in Q4 2024.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.